Table 1.
Economic Evaluation of the Diabetic Individual’s Clinical Pathway Derived from Delhi Approach Implementation
| Traditional Instruments – “AS IS” Scenario | ||||
| Health Expenditure Items | Economic Evaluation of an Individual Who Has Not Experienced a Therapy Switch Within a 12-Month Time Horizon | Economic Evaluation of an Individual Who Has Experienced a Therapy Switch Within a 12-Month Time Horizon | ||
| Economic Value | % | Economic Value | % | |
| Laboratory exams | € 68.67 | 31.89% | € 74.08 | 26.66% |
| Specialist visits | € 55.99 | 26.00% | € 68.59 | 24.68% |
| Diagnostic procedures | € 18.66 | 8.67% | € 20.01 | 7.20% |
| Self-monitoring of blood glucose | € 72.00 | 33.44% | € 115.20 | 41.46% |
| Annual management medical cost | € 215.31 | 100.00% | € 277.88 | 100.00% |
| Traditional Instruments + GA – “TO BE” Scenario | ||||
| Health Expenditure Items | Economic Evaluation of an Individual Who Has Not Experienced a Therapy Switch Within a 12-Month Time Horizon | Economic Evaluation of an Individual Who Has Experienced a Therapy Switch Within a 12-Month Time Horizon | ||
| Economic Value | % | Economic Value | % | |
| Laboratory exams | € 79.92 | 35.27% | € 96.70 | 32.18% |
| Specialist visits | € 55.99 | 24.71% | € 68.59 | 22.83% |
| Diagnostic procedures | € 18.66 | 8.24% | € 20.01 | 6.66% |
| Self-monitoring of blood glucose | € 72.00 | 31.78% | € 115.20 | 38.34% |
| Annual management medical cost | € 226.56 | 100.00% | € 300.50 | 100.00% |